{"entity":{"type":"insider","cik":"0001260943","url":"/insider/0001260943","json_url":"/insider/0001260943.json","name":"THOMAS H. LEE ADVISORS, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":143,"n_filings":90,"first":"2007-02-07","last":"2023-11-09","span_basis":"filed_date"},"name_variants":[{"name":"THOMAS H. LEE ADVISORS, LLC","source":"filing","n_filings":87,"first_seen":"2011-07-22","last_seen":"2023-11-09"},{"name":"LEE THOMAS H ADVISORS LLC","source":"filing","n_filings":3,"first_seen":"2007-02-07","last_seen":"2010-06-22"}],"transactions":[{"id":8731315,"accession":"0001140361-23-052482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-052482","line_url":"/filing/0001140361-23-052482#line-1","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Dun & Bradstreet Holdings, Inc.","issuer_ticker":"DNB","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL EQUITY ADVISORS VIII, LLC; THL Equity Fund VIII Investors (D&B), L.P.; THL Executive Fund VIII, L.P.; THL FUND VIII COINVESTMENT PARTNERS, L.P.; THL HOLDCO, LLC; THL MANAGERS VIII, LLC; THOMAS H LEE PARTNERS LP; THOMAS H. LEE ADVISORS, LLC; Thomas H. Lee Equity Fund VIII, L.P.; Thomas H. Lee Parallel Fund VIII, L.P.","owner_display_name":"THL EQUITY ADVISORS VIII, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13396742.0,"shares_display":"13,396,742","price_per_share":9.512,"price_display":"9.51","price_state":"stated","total_value":127429809.904,"total_display":"127,429,809.90","total_whole":"127,429,810","shares_owned_after":22525103.0,"shares_owned_after_display":"22,525,103","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-07","filed_date":"2023-11-09","scope":"insider"},{"id":8246550,"accession":"0001140361-23-052483","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-052483","line_url":"/filing/0001140361-23-052483#line-1","is_derivative":false,"issuer_cik":"0001058835","issuer_name":"Dun & Bradstreet Holdings, Inc.","issuer_ticker":"DNB","issuer_name_source":null,"issuer_url":"/issuer/0001058835","owner_cik":null,"owner_name":"HAGERTY THOMAS M; Rao Gnaneshwar B.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"HAGERTY THOMAS M","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13396742.0,"shares_display":"13,396,742","price_per_share":9.512,"price_display":"9.51","price_state":"stated","total_value":127429809.904,"total_display":"127,429,809.90","total_whole":"127,429,810","shares_owned_after":22525103.0,"shares_owned_after_display":"22,525,103","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-07","filed_date":"2023-11-09","scope":"insider"},{"id":8182223,"accession":"0001140361-23-038829","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-038829","line_url":"/filing/0001140361-23-038829#line-1","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Dun & Bradstreet Holdings, Inc.","issuer_ticker":"DNB","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL EQUITY ADVISORS VIII, LLC; THL Equity Fund VIII Investors (D&B), L.P.; THL Executive Fund VIII, L.P.; THL FUND VIII COINVESTMENT PARTNERS, L.P.; THL HOLDCO, LLC; THL MANAGERS VIII, LLC; THOMAS H LEE PARTNERS LP; THOMAS H. LEE ADVISORS, LLC; Thomas H. Lee Equity Fund VIII, L.P.; Thomas H. Lee Parallel Fund VIII, L.P.","owner_display_name":"THL EQUITY ADVISORS VIII, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13657926.0,"shares_display":"13,657,926","price_per_share":11.115,"price_display":"11.12","price_state":"stated","total_value":151807847.49,"total_display":"151,807,847.49","total_whole":"151,807,847","shares_owned_after":35921845.0,"shares_owned_after_display":"35,921,845","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-09","scope":"insider"},{"id":7966075,"accession":"0001140361-23-038839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-038839","line_url":"/filing/0001140361-23-038839#line-1","is_derivative":false,"issuer_cik":"0001058835","issuer_name":"Dun & Bradstreet Holdings, Inc.","issuer_ticker":"DNB","issuer_name_source":null,"issuer_url":"/issuer/0001058835","owner_cik":null,"owner_name":"HAGERTY THOMAS M; Rao Gnaneshwar B.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"HAGERTY THOMAS M","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13657926.0,"shares_display":"13,657,926","price_per_share":11.115,"price_display":"11.12","price_state":"stated","total_value":151807847.49,"total_display":"151,807,847.49","total_whole":"151,807,847","shares_owned_after":35921845.0,"shares_owned_after_display":"35,921,845","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-09","scope":"insider"},{"id":6887663,"accession":"0001140361-22-042633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-042633","line_url":"/filing/0001140361-22-042633#line-1","is_derivative":false,"issuer_cik":"0001058835","issuer_name":"Dun & Bradstreet Holdings, Inc.","issuer_ticker":"DNB","issuer_name_source":null,"issuer_url":"/issuer/0001058835","owner_cik":null,"owner_name":"HAGERTY THOMAS M; Rao Gnaneshwar B.; THL MANAGERS VIII, LLC; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"HAGERTY THOMAS M","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8287846.0,"shares_display":"8,287,846","price_per_share":13.405,"price_display":"13.40","price_state":"stated","total_value":111098575.63,"total_display":"111,098,575.63","total_whole":"111,098,576","shares_owned_after":49579771.0,"shares_owned_after_display":"49,579,771","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-21","scope":"insider"},{"id":6506820,"accession":"0001140361-22-042632","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-042632","line_url":"/filing/0001140361-22-042632#line-1","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Dun & Bradstreet Holdings, Inc.","issuer_ticker":"DNB","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL EQUITY ADVISORS VIII, LLC; THL Equity Fund VIII Investors (D&B), L.P.; THL Executive Fund VIII, L.P.; THL FUND VIII COINVESTMENT PARTNERS, L.P.; THL HOLDCO, LLC; THOMAS H LEE PARTNERS LP; THOMAS H. LEE ADVISORS, LLC; Thomas H. Lee Equity Fund VIII, L.P.; Thomas H. Lee Parallel Fund VIII, L.P.","owner_display_name":"THL EQUITY ADVISORS VIII, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8287846.0,"shares_display":"8,287,846","price_per_share":13.405,"price_display":"13.40","price_state":"stated","total_value":111098575.63,"total_display":"111,098,575.63","total_whole":"111,098,576","shares_owned_after":49579771.0,"shares_owned_after_display":"49,579,771","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-21","scope":"insider"},{"id":5150394,"accession":"0001140361-21-020396","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-21-020396","line_url":"/filing/0001140361-21-020396","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"THL Equity Fund VII Investors (inVentiv), L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5044187.0,"shares_display":"5,044,187","price_per_share":81.2,"price_display":"81.20","price_state":"stated","total_value":409587984.4,"total_display":"409,587,984.40","total_whole":"409,587,984","shares_owned_after":391991.0,"shares_owned_after_display":"391,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider","n_lines":6},{"id":4412759,"accession":"0001140361-21-020386","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-21-020386","line_url":"/filing/0001140361-21-020386","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Fund VI (2019) Coinvestment Partners, L.P.; THL HOLDCO, LLC; THL Managers VI, LLC; THL Managers VII, LLC; THOMAS H LEE PARTNERS LP; THOMAS H. LEE ADVISORS, LLC; Thomas H. Lee Equity Fund VI (2019), L.P.; Thomas H. Lee Equity Fund VII, L.P.; Thomas H. Lee Parallel (Cayman) Fund VII, L.P.; Thomas H. Lee Parallel Fund VII, L.P.","owner_display_name":"THL Fund VI (2019) Coinvestment Partners, L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5044187.0,"shares_display":"5,044,187","price_per_share":81.2,"price_display":"81.20","price_state":"stated","total_value":409587984.4,"total_display":"409,587,984.40","total_whole":"409,587,984","shares_owned_after":391991.0,"shares_owned_after_display":"391,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider","n_lines":6},{"id":9233586,"accession":"0001140361-21-018266","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-21-018266","line_url":"/filing/0001140361-21-018266","is_derivative":false,"issuer_cik":"0001713160","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001713160","owner_cik":null,"owner_name":"THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"THL Equity Fund VII Investors (inVentiv), L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":379878.0,"shares_display":"379,878","price_per_share":81.04,"price_display":"81.04","price_state":"stated","total_value":30785313.12,"total_display":"30,785,313.12","total_whole":"30,785,313","shares_owned_after":852.0,"shares_owned_after_display":"852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-20","scope":"insider","n_lines":3},{"id":9233583,"accession":"0001140361-21-018265","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-21-018265","line_url":"/filing/0001140361-21-018265","is_derivative":false,"issuer_cik":"0001753032","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001753032","owner_cik":null,"owner_name":"THL Fund VI (2019) Coinvestment Partners, L.P.; THL HOLDCO, LLC; THL Managers VI, LLC; THL Managers VII, LLC; THOMAS H LEE PARTNERS LP; THOMAS H. LEE ADVISORS, LLC; Thomas H. Lee Equity Fund VI (2019), L.P.; Thomas H. Lee Equity Fund VII, L.P.; Thomas H. Lee Parallel (Cayman) Fund VII, L.P.; Thomas H. Lee Parallel Fund VII, L.P.","owner_display_name":"THL Fund VI (2019) Coinvestment Partners, L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":379878.0,"shares_display":"379,878","price_per_share":81.04,"price_display":"81.04","price_state":"stated","total_value":30785313.12,"total_display":"30,785,313.12","total_whole":"30,785,313","shares_owned_after":852.0,"shares_owned_after_display":"852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-20","scope":"insider","n_lines":3},{"id":4412737,"accession":"0001140361-21-017953","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-21-017953","line_url":"/filing/0001140361-21-017953","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"THL Equity Fund VII Investors (inVentiv), L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":379878.0,"shares_display":"379,878","price_per_share":81.04,"price_display":"81.04","price_state":"stated","total_value":30785313.12,"total_display":"30,785,313.12","total_whole":"30,785,313","shares_owned_after":5208835.0,"shares_owned_after_display":"5,208,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-18","scope":"insider","n_lines":3},{"id":4318609,"accession":"0001140361-21-017952","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-21-017952","line_url":"/filing/0001140361-21-017952","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Fund VI (2019) Coinvestment Partners, L.P.; THL HOLDCO, LLC; THL Managers VI, LLC; THL Managers VII, LLC; THOMAS H LEE PARTNERS LP; THOMAS H. LEE ADVISORS, LLC; Thomas H. Lee Equity Fund VI (2019), L.P.; Thomas H. Lee Equity Fund VII, L.P.; Thomas H. Lee Parallel (Cayman) Fund VII, L.P.; Thomas H. Lee Parallel Fund VII, L.P.","owner_display_name":"THL Fund VI (2019) Coinvestment Partners, L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":379878.0,"shares_display":"379,878","price_per_share":81.04,"price_display":"81.04","price_state":"stated","total_value":30785313.12,"total_display":"30,785,313.12","total_whole":"30,785,313","shares_owned_after":5208835.0,"shares_owned_after_display":"5,208,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-18","scope":"insider","n_lines":3},{"id":4735205,"accession":"0001140361-21-016730","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-21-016730","line_url":"/filing/0001140361-21-016730","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Fund VI (2019) Coinvestment Partners, L.P.; THL HOLDCO, LLC; THL Managers VI, LLC; THL Managers VII, LLC; THOMAS H LEE PARTNERS LP; THOMAS H. LEE ADVISORS, LLC; Thomas H. Lee Equity Fund VI (2019), L.P.; Thomas H. Lee Equity Fund VII, L.P.; Thomas H. Lee Parallel (Cayman) Fund VII, L.P.; Thomas H. Lee Parallel Fund VII, L.P.","owner_display_name":"THL Fund VI (2019) Coinvestment Partners, L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3391682.0,"shares_display":"3,391,682","price_per_share":81.04,"price_display":"81.04","price_state":"stated","total_value":274861909.28,"total_display":"274,861,909.28","total_whole":"274,861,909","shares_owned_after":5899055.0,"shares_owned_after_display":"5,899,055","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-06","filed_date":"2021-05-10","scope":"insider","n_lines":6},{"id":4172717,"accession":"0001140361-21-016731","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-21-016731","line_url":"/filing/0001140361-21-016731","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"THL Equity Fund VII Investors (inVentiv), L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3391682.0,"shares_display":"3,391,682","price_per_share":81.04,"price_display":"81.04","price_state":"stated","total_value":274861909.28,"total_display":"274,861,909.28","total_whole":"274,861,909","shares_owned_after":5899055.0,"shares_owned_after_display":"5,899,055","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-06","filed_date":"2021-05-10","scope":"insider","n_lines":6},{"id":4962864,"accession":"0001140361-21-007502","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-21-007502","line_url":"/filing/0001140361-21-007502","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"THL Equity Fund VII Investors (inVentiv), L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3995954.0,"shares_display":"3,995,954","price_per_share":74.175,"price_display":"74.18","price_state":"stated","total_value":296399887.95,"total_display":"296,399,887.95","total_whole":"296,399,888","shares_owned_after":9517640.0,"shares_owned_after_display":"9,517,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-05","scope":"insider","n_lines":6},{"id":4464552,"accession":"0001140361-21-007501","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-21-007501","line_url":"/filing/0001140361-21-007501#line-6","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Fund VI (2019) Coinvestment Partners, L.P.; THL HOLDCO, LLC; THL Managers VI, LLC; THL Managers VII, LLC; THOMAS H LEE PARTNERS LP; THOMAS H. LEE ADVISORS, LLC; Thomas H. Lee Equity Fund VI (2019), L.P.; Thomas H. Lee Equity Fund VII, L.P.; Thomas H. Lee Parallel (Cayman) Fund VII, L.P.; Thomas H. Lee Parallel Fund VII, L.P.","owner_display_name":"THL Fund VI (2019) Coinvestment Partners, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3717905.0,"shares_display":"3,717,905","price_per_share":74.175,"price_display":"74.18","price_state":"stated","total_value":275775603.375,"total_display":"275,775,603.38","total_whole":"275,775,603","shares_owned_after":9517640.0,"shares_owned_after_display":"9,517,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-05","scope":"insider"},{"id":4464548,"accession":"0001140361-21-007501","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-21-007501","line_url":"/filing/0001140361-21-007501#line-5","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Fund VI (2019) Coinvestment Partners, L.P.; THL HOLDCO, LLC; THL Managers VI, LLC; THL Managers VII, LLC; THOMAS H LEE PARTNERS LP; THOMAS H. LEE ADVISORS, LLC; Thomas H. Lee Equity Fund VI (2019), L.P.; Thomas H. Lee Equity Fund VII, L.P.; Thomas H. Lee Parallel (Cayman) Fund VII, L.P.; Thomas H. Lee Parallel Fund VII, L.P.","owner_display_name":"THL Fund VI (2019) Coinvestment Partners, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":277114.0,"shares_display":"277,114","price_per_share":74.175,"price_display":"74.18","price_state":"stated","total_value":20554930.95,"total_display":"20,554,930.95","total_whole":"20,554,931","shares_owned_after":9106651.0,"shares_owned_after_display":"9,106,651","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-05","scope":"insider"}],"collapsed":true,"next_cursor":"2021-03-03|4464548","ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001799208","name":"Dun & Bradstreet Holdings, Inc.","url":"/issuer/0001799208","role":"Director, Ten percent owner","n_filings":6,"first_seen":"2022-11-21","last_seen":"2023-11-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001610950","name":"Syneos Health, Inc.","url":"/issuer/0001610950","role":"Director, Ten percent owner","n_filings":16,"first_seen":"2018-08-13","last_seen":"2021-06-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001725057","name":"Ceridian HCM Holding Inc.","url":"/issuer/0001725057","role":"Director, Ten percent owner","n_filings":20,"first_seen":"2018-11-20","last_seen":"2020-08-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001273931","name":"MONEYGRAM INTERNATIONAL INC","url":"/issuer/0001273931","role":"Director, Ten percent owner, Other","n_filings":4,"first_seen":"2011-11-28","last_seen":"2019-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001592058","name":"Party City Holdco Inc.","url":"/issuer/0001592058","role":"Director, Ten percent owner","n_filings":6,"first_seen":"2017-12-13","last_seen":"2018-08-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001627014","name":"Black Knight, Inc.","url":"/issuer/0001627014","role":"Director, Ten percent owner","n_filings":13,"first_seen":"2017-05-16","last_seen":"2018-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001627487","name":"Fogo de Chao, Inc.","url":"/issuer/0001627487","role":"Ten percent owner","n_filings":4,"first_seen":"2017-05-19","last_seen":"2018-04-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001584509","name":"Aramark","url":"/issuer/0001584509","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2013-12-19","last_seen":"2015-08-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001024657","name":"WEST CORP","url":"/issuer/0001024657","role":"Ten percent owner","n_filings":3,"first_seen":"2015-03-20","last_seen":"2015-07-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001077771","name":"UMPQUA HOLDINGS CORP","url":"/issuer/0001077771","role":"Ten percent owner","n_filings":1,"first_seen":"2014-08-14","last_seen":"2014-08-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001357204","name":"DUNKIN' BRANDS GROUP, INC.","url":"/issuer/0001357204","role":"Ten percent owner","n_filings":5,"first_seen":"2011-08-03","last_seen":"2012-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001319161","name":"Warner Music Group Corp.","url":"/issuer/0001319161","role":"Ten percent owner","n_filings":1,"first_seen":"2011-07-22","last_seen":"2011-07-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001325740","name":"Advanced BioEnergy, LLC","url":"/issuer/0001325740","role":"Ten percent owner","n_filings":2,"first_seen":"2009-09-25","last_seen":"2010-06-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001062613","name":"FAIRPOINT COMMUNICATIONS INC","url":"/issuer/0001062613","role":"Ten percent owner","n_filings":1,"first_seen":"2007-02-07","last_seen":"2007-02-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001260943","retrieved_at":"2026-08-24T13:21:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}